Generation of KS-133 as a Novel Bicyclic Peptide with a Potent and Selective VIPR2 Antagonist Activity that Counteracts Cognitive Decline in a Mouse Model of Psychiatric DisordersKotaro Sakamoto, Yukio Ago, Tatsunori Miyaoka et al.|Frontiers in Pharmacology|2021Cited by 16